ResearcherAffiliated Hospital of Jiangsu UniversityActive in the last 2 years

Xi Pu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0008-2100-0524; OpenAlex author ID A5038568138. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2023: 1 paper · 2024: none · 2025: 1 paper

Papers 2

The m6A reader IGF2BP2 promotes pancreatic cancer progression through the m6A-SLC1A5-mTORC1 axis. Co-author DOI 10.1186/s12935-025-03736-8 ↗
PYGL-mediated glucose metabolism reprogramming promotes EMT phenotype and metastasis of pancreatic cancer. Co-author DOI 10.7150/ijbs.76756 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Min Xu · 1 shared paper, 2025 · strength 0.27
- Paper The m6A reader IGF2BP2 promotes pancreatic cancer progression through the m6A-SLC1A5-mTORC1 axis. DOI 10.1186/s12935-025-03736-8 ↗
Rongkun Li · 1 shared paper, 2023 · strength 0.17
- Paper PYGL-mediated glucose metabolism reprogramming promotes EMT phenotype and metastasis of pancreatic cancer. DOI 10.7150/ijbs.76756 ↗
Hengchao Li · 1 shared paper, 2023 · strength 0.17
- Paper PYGL-mediated glucose metabolism reprogramming promotes EMT phenotype and metastasis of pancreatic cancer. DOI 10.7150/ijbs.76756 ↗
Qian Ji · 1 shared paper, 2023 · strength 0.17
- Paper PYGL-mediated glucose metabolism reprogramming promotes EMT phenotype and metastasis of pancreatic cancer. DOI 10.7150/ijbs.76756 ↗
Chongyi Jiang · 1 shared paper, 2023 · strength 0.17
- Paper PYGL-mediated glucose metabolism reprogramming promotes EMT phenotype and metastasis of pancreatic cancer. DOI 10.7150/ijbs.76756 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.